SAT0247 Impact of glucocorticoids on efficacy and safety of tofacitinib with and without methotrexate and adalimumab with methotrexate for rheumatoid arthritis: results from a phase 3b/4 randomised trial
Fleischmann, R., Wollenhaupt, J., Cohen, S., Smolen, J. S., Dahl, P., Iikuni, N., Shi, H., Tatulych, S., Takiya, L.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index
Dikranian, A., Gonzalez-Gay, M. A., Wellborne, F., Alvaro-Gracia, J. M., Takiya, L., Stockert, L., Chapman, D., Tatulych, S., Dahl, P., Curtis, J. R.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article
Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis
Schaefer, C., Mamolo, C., Cappelleri, J.C., Daniel, S., Le, C., Tatulych, S., Griffiths, C.E.M., Hampton, P.J.
Published in British journal of dermatology (1951) (01.09.2017)
Published in British journal of dermatology (1951) (01.09.2017)
Get full text
Journal Article
THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials
Langley, R.G.B., Cohen, A.D., Foley, P., Griffiths, C.E.M., Lebwohl, M., Leonardi, C., Winthrop, K., Proulx, J., Rottinghaus, S.T., Wolk, R., Thompson, J.R., Tatulych, S., Mallbris, L., Swanson, R.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
077 Effect of Cytochrome P450 Inhibition and Induction and Organic Anion Transporter 3 Inhibition on the Pharmacokinetics of Abrocitinib Active Moiety in Healthy Individuals
Wang, X., Dowty, M.E., Wouters, A., Tatulych, S., Connell, C., Le, V., Valdez, H., Malhotra, B.K.
Published in Journal of investigative dermatology (01.10.2021)
Published in Journal of investigative dermatology (01.10.2021)
Get full text
Journal Article
POS1293 TEN-YEAR EFFICACY DATA FROM THE CLIPPER STUDIES: OPEN-LABEL, LONG-TERM ETANERCEPT TREATMENT IN CHILDREN AND YOUNG ADULTS WITH EXTENDED OLIGOARTICULAR, ENTHESITIS-RELATED, OR PSORIATIC JUVENILE IDIOPATHIC ARTHRITIS
Vojinovic, J., Dehoorne, J., Panaviene, V., Susic, G., Horneff, G., Stanevicha, V., Kobusinska, K., Żuber, Z., Dobrzyniecka, B., Akikusa, J., Avcin, T., Martini, A., Borlenghi, C., Arthur, E., Tatulych, S. Y., Zang, C., Tsekouras, V., Vlahos, B., Ruperto, N.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS0169 OPEN-LABEL, LONG-TERM (10-YEAR) STUDY OF THE SAFETY OF ETANERCEPT IN CHILDREN AND YOUNG ADULTS WITH EXTENDED OLIGOARTICULAR, ENTHESITIS-RELATED, OR PSORIATIC JUVENILE IDIOPATHIC ARTHRITIS
Vojinovic, J., Dehoorne, J., Panaviene, V., Susic, G., Horneff, G., Stanevicha, V., Kobusinska, K., Żuber, Z., Dobrzyniecka, B., Akikusa, J., Avcin, T., Martini, A., Borlenghi, C., Arthur, E., Tatulych, S. Y., Zang, C., Vlahos, B., Ruperto, N.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
Papp, Kim A., MD, PhD, Krueger, James G., MD, PhD, Feldman, Steven R., MD, PhD, Langley, Richard G., MD, Thaci, Diamant, MD, Torii, Hideshi, MD, PhD, Tyring, Stephen, MD, PhD, Wolk, Robert, MD, PhD, DSc, Gardner, Annie, MS, Mebus, Charles, PhD, Tan, Huaming, PhD, Luo, Yingchun, PhD, Gupta, Pankaj, PhD, Mallbris, Lotus, MD, PhD, Tatulych, Svitlana, MD
Published in Journal of the American Academy of Dermatology (01.05.2016)
Published in Journal of the American Academy of Dermatology (01.05.2016)
Get full text
Journal Article
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis
Feldman, Steven R., MD, PhD, Thaçi, Diamant, MD, PhD, Gooderham, Melinda, MD, MSc, Augustin, Matthias, MD, Cruz, Claudia de la, MD, Mallbris, Lotus, MD, PhD, Buonanno, Marjorie, MSN, Tatulych, Svitlana, MD, Kaur, Mandeep, MD, MS, Lan, Shuping, MS, MPH, Valdez, Hernan, MD, Mamolo, Carla, PhD
Published in Journal of the American Academy of Dermatology (01.12.2016)
Published in Journal of the American Academy of Dermatology (01.12.2016)
Get full text
Journal Article
LB0003 Tofacitinib with and without methotrexate versus adalimumab with methotrexate for the treatment of rheumatoid arthritis: results from oral strategy, a phase 3b/4 randomised trial
Fleischmann, R, Mysler, E, Hall, S, Kivitz, A, Moots, R, Luo, Z, Tatulych, S, DeMasi, R, Soma, K, Zhang, R, Takiya, L, Mojcik, C, Krishnaswami, S, Menon, S, Smolen, J
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
Pathological immune pathways in psoriasis are rapidly attenuated by tofacitinib treatment
Krueger, J, Suarez-Farinas, M, Fuentes-Duculan, J, Cueto, I, Mallbris, L, Tatulych, S, Clark, J, Tan, H, Wolk, R, Rottinghaus, S, Whitley, M, Valdez, H, von Schack, D, Stewart, Z, Zhan, Y
Published in BRITISH JOURNAL OF DERMATOLOGY (2014)
Get full text
Published in BRITISH JOURNAL OF DERMATOLOGY (2014)
Conference Proceeding